ConductScience.org, home

Paper17544165

Lipid nanoparticles for improved topical application of drugs for skin diseases.

Schäfer-Korting M and 2 others. Adv Drug Deliv Rev, 2007. Cited by 368 papers, by iCite.

Cite this record

ConductScience Library. Lipid nanoparticles for improved topical application of drugs for skin diseases. Papers, record 17544165. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17544165

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lipid nanoparticles for improved topical application of drugs for skin diseases.
PubMed
Journal
Adv Drug Deliv Rev
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
368
iCite
Relative citation ratio, by iCite
13.2
iCite
Revised in PubMed
2007-08-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schäfer-Korting MMonika
2Mehnert WWolfgang
3Korting HCHans-Christian

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug CarriersMajor topic
NanoparticlesMajor topic
Skin DiseasesMajor topic
Administration, Topical
Animals
Humans
Lipids
Pharmaceutical Preparations
Skin Absorption

Source PubMed

Download CSV of topics

Cited by118

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 368 citations.

PMIDTitleJournalYearIn PapersSource
42840803Lipid matrix composition-tuned nanoparticles for enhanced topical retinol delivery and anti-photoaging efficacy.Int J Pharm X2026https://conductscience.org/library/papers/42840803PubMed
42755299Lipid-Based Nanocarriers for Intranasal Delivery: Revolutionizing Neurological Disorder Therapies.Curr Top Med Chem2026https://conductscience.org/library/papers/42755299PubMed
42514932In Vitro and Ex Vivo Studies on the Absorption and Distribution of β-Cyclodextrin Polymer.Pharmaceutics2026https://conductscience.org/library/papers/42514932PubMed
42220974Lipid-Based Nanocarriers for Curcumin Delivery: A Promising Strategy in The Management of Inflammatory Diseases.Int J Nanomedicine2026https://conductscience.org/library/papers/42220974PubMed
42076079Advances in Nanotechnology-Assisted Delivery of TCM-Derived Bioactive Compounds for Wound Repair.Pharmaceutics2026https://conductscience.org/library/papers/42076079PubMed
41599167Quality by Design for the Nanoformulation of Cosmeceuticals.Pharmaceutics2026https://conductscience.org/library/papers/41599167PubMed
41079789Validation of breast cancer as a risk factor for anxiety and depression: Insights from Mendelian randomization analysis.J Pharm Anal2025https://conductscience.org/library/papers/41079789PubMed
40299379Novel Small-Molecule Treatment and Emerging Biological Therapy for Psoriasis.Biomedicines2025https://conductscience.org/library/papers/40299379PubMed
40277615Smart Nanocarriers in Cosmeceuticals Through Advanced Delivery Systems.Biomimetics (Basel)2025https://conductscience.org/library/papers/40277615PubMed
39830167Metabolomic profiling and antibacterial efficacy of probiotic-derived cell-free supernatant encapsulated in nanostructured lipid carriers against canine multidrug-resistant bacteria.Front Vet Sci2024https://conductscience.org/library/papers/39830167PubMed
39403134Hyaluronic acid-solid lipid nano transporter serum preparation for enhancing topical tretinoin delivery: skin safety study and visual assessment of skin.Front Pharmacol2024https://conductscience.org/library/papers/39403134PubMed
39400025Optimization, Formulation, and Ex vivo Evaluation of Solid Lipid Nanoparticles for Transdermal Delivery of Diltiazem Hydrochloride.Pharm Nanotechnol2026https://conductscience.org/library/papers/39400025PubMed
39384727New Insight for Enhanced Topical Targeting of Caffeine for Effective Cellulite Treatment: In Vitro Characterization, Permeation Studies, and Histological Evaluation in Rats.AAPS PharmSciTech2024https://conductscience.org/library/papers/39384727PubMed
39082164Topical Administration of Nanostructured Lipid Carriers as a Viable Approach to Reduce Inflammation: A Review.Antiinflamm Antiallergy Agents Med Chem2025https://conductscience.org/library/papers/39082164PubMed
39022452Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications.J Lipids2024https://conductscience.org/library/papers/39022452PubMed
38675215Microemulsions and Nanoemulsions for Topical Delivery of Tripeptide-3: From Design of Experiment to Anti-Sebum Efficacy on Facial Skin.Pharmaceutics2024https://conductscience.org/library/papers/38675215PubMed
38675110Recent Approaches for the Topical Treatment of Psoriasis Using Nanoparticles.Pharmaceutics2024https://conductscience.org/library/papers/38675110PubMed
38639280Nanogels as Drug Delivery Carrier: A Narrative Review on Formulation Techniques, Characterization, Applications and Patents.Curr Pharm Biotechnol2025https://conductscience.org/library/papers/38639280PubMed
38585452Green Formulation of Spironolactone Loaded Chitosan-Coated Nano Lipid Carrier for Treatment of Acne Vulgaris: A Randomized Double-Blind Clinical Trial.Adv Pharm Bull2024https://conductscience.org/library/papers/38585452PubMed
38435752Development of Curcumin and Turmerone Loaded Solid Lipid Nanoparticle for Topical Delivery: Optimization, Characterization and Skin Irritation Evaluation with 3D Tissue Model.Int J Nanomedicine2024https://conductscience.org/library/papers/38435752PubMed

See all 118 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17544165

GET https://conductscience.org/api/papers/v1/17544165/cited_by?page=2